HCM & Felcyin-CA1: What You Need to Know with Dr. Ashlie Saffire

Cost

Free/Sponsored

September 2025

In today’s VETgirl online veterinary continuing education podcast, Dr. Ashlie Saffire, DAVBP (feline practice), discusses Felcyin-CA1 (sirolimus delayed-release tablets), an FDA conditionally approved treatment option to slow the progression of hypertrophic cardiomyopathy (HCM) in cats manufactured by PRN Pharmacal. HCM is known as the silent killer in cats! Tune in to find out if Felycin-CA1 is the right choice for your HCM patient!

If you missed the podcast discussion from January 2025 Does Rapamycin Halt Progression of Left Ventricular Hypertrophy in Feline HCM? Check it out HERE.

Today’s VETgirl podcast is sponsored in part by PRN Pharmacal, a company committed to advancing pet health through innovative solutions. For the first time, veterinarians have access to an FDA conditionally approved treatment that helps slow the progression of hypertrophic cardiomyopathy (HCM) in cats, Felycin-CA1 (sirolimus delayed-release tablets). This groundbreaking therapy addresses a critical unmet need in feline cardiology, offering new hope for helping cats with HCM live longer, healthier lives. Learn more at felycin.com.

Not a VETgirl ELITE member? Get your learning on with the #1 veterinary CE resource – clinically relevant, practical, and accessible 24/7 on your own time! Don’t miss out – click HERE to check out your options, including our new  14-day, no-commitment ELITE Trial.

Only VETgirl members can leave comments. Sign In or Join VETgirl now!